Cancer Prevention & Control Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC.
Department of Biostatistics, Bioinformatics and Biomathematics, Georgetown University, Washington, DC.
Cancer. 2022 May 1;128(9):1812-1819. doi: 10.1002/cncr.34098. Epub 2022 Feb 24.
In 2021, the US Preventive Services Task Force (USPSTF) expanded the eligibility criteria for low-dose computed tomographic lung cancer screening (LCS) to reduce racial disparities that resulted from the 2013 USPSTF criteria. The annual LCS rate has risen slowly since the 2013 USPSTF screening recommendations. Using the 2019 Behavioral Risk Factor Surveillance System (BRFSS), this study 1) describes LCS use in 2019, 2) compares the percent eligible for LCS using the 2013 versus 2021 USPSTF criteria, and 3) determines the percent eligible using the more detailed PLCOm2012 risk-prediction model.
The analysis included 41,544 individuals with a smoking history from states participating in the BRFSS LCS module who were ≥50 years old.
Using the 2013 USPSTF criteria, 20.7% (95% confidence interval [CI], 19.0-22.4) of eligible individuals underwent LCS in 2019. The 2013 USPSTF criteria was compared to the 2021 USPSTF criteria, and the overall proportion eligible increased from 21.0% (95% CI, 20.2-21.8) to 34.7% (95 CI, 33.8-35.6). Applying the 2021 criteria, the proportion eligible by race was 35.8% (95% CI, 34.8-36.7) among Whites, 28.5% (95% CI, 25.2-31.9) among Blacks, and 18.0% (95% CI, 12.4-23.7) among Hispanics. Using the 1.0% 6-year threshold that is comparable to the 2021 USPSTF criteria, the PLCOm2012 model selected more individuals overall and by race.
Using data from 20 states and using multiple imputation, higher LCS rates have been reported compared to prior BRFSS data. The 2021 expanded criteria will result in a greater number of screen-eligible individuals. However, risk-based screening that uses additional risk factors may be more inclusive overall and across subgroups.
In 2013, lung cancer screening (lung screening) was recommended for high risk individuals. The annual rate of lung screening has risen slowly, particularly among Black individuals. In part, this racial disparity resulted in expanded 2021 criteria. Survey data was used to: 1) describe the number of people screened in 2019, 2) compare the percent eligible for lung screening using the 2013 versus 2021 guidelines, and 3) determine the percent eligible using more detailed criteria. Lung screening rates increased in 2019, and the 2021 criteria will result in more individuals eligible for screening. Using additional criteria may identify more individuals eligible for lung screening.
2021 年,美国预防服务工作组(USPSTF)扩大了低剂量计算机断层扫描肺癌筛查(LCS)的资格标准,以减少 2013 年 USPSTF 标准导致的种族差异。自 2013 年 USPSTF 筛查建议以来,每年的 LCS 率增长缓慢。本研究使用 2019 年行为风险因素监测系统(BRFSS),1)描述 2019 年 LCS 的使用情况,2)比较使用 2013 年和 2021 年 USPSTF 标准的 LCS 资格百分比,3)使用更详细的 PLCOm2012 风险预测模型确定有资格的百分比。
分析包括来自参加 BRFSS LCS 模块的有吸烟史的 41544 名年龄在 50 岁以上的个体。
使用 2013 年 USPSTF 标准,2019 年有 20.7%(95%置信区间[CI],19.0-22.4)的合格个体接受了 LCS。将 2013 年 USPSTF 标准与 2021 年 USPSTF 标准进行比较,有资格的总比例从 21.0%(95% CI,20.2-21.8)增加到 34.7%(95% CI,33.8-35.6)。应用 2021 年标准,白种人有资格的比例为 35.8%(95% CI,34.8-36.7),黑人有资格的比例为 28.5%(95% CI,25.2-31.9),西班牙裔有资格的比例为 18.0%(95% CI,12.4-23.7)。使用与 2021 年 USPSTF 标准相当的 1.0%6 年阈值,PLCOm2012 模型总体上和按种族选择了更多的个体。
使用来自 20 个州的数据和使用多重插补,与之前的 BRFSS 数据相比,报告的 LCS 率有所上升。2021 年扩大的标准将导致更多的筛查合格者。然而,使用额外风险因素的基于风险的筛查可能在总体上和在各个亚组中更具包容性。
2013 年,肺癌筛查(肺癌筛查)被推荐用于高危人群。肺癌筛查的年度率增长缓慢,特别是在黑人中。部分原因是这种种族差异导致了 2021 年扩大的标准。调查数据被用于:1)描述 2019 年筛查的人数,2)比较使用 2013 年和 2021 年指南的合格百分比,3)使用更详细的标准确定合格百分比。2019 年肺癌筛查率有所上升,2021 年的标准将使更多的人有资格接受筛查。使用额外的标准可能会确定更多有资格接受肺癌筛查的人。